Zhitong Financial App News, TATA Health (01255) released interim results for the six months ended June 30, 2021. The group earned HK $73.116 million in revenue during the period, down 7.56% from the same period last year; the loss attributable to shareholders was HK $27.083 million, down 68.23% from the same period last year; and a loss per share of HK $0.123.

It is reported that the gross profit of the group during the reporting period was about HK $44.1 million, an increase of about 297.2% over the same period last year, and the gross profit margin was about 60.3% (June 30, 2020: about 14.1%). The increase in gross profit margin was mainly due to inventory impairment during the period, compared with an impact of approximately HK $3.7 million in the cost of sales in the same period last year. In addition, revenue from the footwear business remained the same as in the same period last year.